Randomized, Double-Blind, Placebo-Controlled, Paralled-Group Study to Investigate the Safety and Tolerability as Well as the Immunological and Clincal Efficacy of Mutiple Subcutaneous Doses of Diapep27 in Lada Subjects

Grants and Contracts Details

StatusFinished
Effective start/end date7/25/021/31/09

Funding

  • Peptor Ltd: $216,930.00